TrialX
Image

RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19

RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19

Recruiting
18 years and older
All
Phase N/A

Overview

the purpose of the study is to study the detection of SARS-Cov-2 virus in the conjunctiva of covid-19 patients and the presence or absence of conjunctivitis in these patients

Eligibility

Inclusion Criteria:

  • Men and Women positive for SARS-Cov-2 on a RT-PCR test of a sample of respiratory airway
  • Persons over 18 years of age
  • patients of both sexes
  • Member of a social security scheme
  • Having signed the consent form

Exclusion Criteria:

  • Minors not emancipated, persons out of state to express their consent
  • Participation in intervention research on Covid-19 involving experimental treatment
  • History of chronic disease conjunctiva
  • Patient with one of the one of the criteria of following gravity:
    1. EN > or =30/min,
    2. Pao2/Fio2 = or < 300,
    3. confusion and/or disorientation,
    4. hypotension (Tas90mmhg, requiring aggressive filling),
    5. need for a invasive ventilation,
    6. septic shock

Study details
    Covid 19
    Conjunctivitus

NCT04397666

Versailles Hospital

16 February 2024

Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.